This Incyte Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Considering buying INCY stock? Here’s what analysts think:

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

HC Wainwright & Co. analyst Mitchell S. Kapoor initiated coverage on Incyte Corp (NASDAQ:INCY) with a Buy rating and announced a price target of $135. Incyte shares closed at $102.60 on Wednesday. See how other analysts view this stock.
Benchmark analyst Todd M. Brooks initiated coverage on CAVA Group, Inc. (NYSE:CAVA) with a Buy rating and announced a price target of $80. Cava shares closed at $65.41 on Wednesday. See how other analysts view this stock.
Cantor Fitzgerald analyst Yanni Souroutzidis initiated coverage on Karyopharm Therapeutics Inc. (NASDAQ:KPTI) with an Overweight rating. Karyopharm Therapeutics shares closed at $6.30 on Wednesday. See how other analysts view this stock.
Benchmark analyst Ben Klieve initiated coverage on The Andersons, Inc. (NASDAQ:ANDE) with a Buy rating and announced a price target of $75. Andersons shares closed at $64.67 on Wednesday. See how other analysts view this stock.